Status:
COMPLETED
Molecular Markers of Prognosis in Colorectal Cancer Patients
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
To correlate the molecular profile of a series of defined CRCs with prognosis and toxicity.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All patients participating in the RMHNHST study of infusional versus bolus 5FU (Saini et al. 2003).
Exclusion
Key Trial Info
Start Date :
November 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT00220142
Start Date
November 1 2003
Last Update
May 31 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Marsden Hospital
Sutton, Surrey, United Kingdom, SM2 5PT